Evidence-Based Pharmacotherapy Strategies for Burn Fluid Resuscitation
Learning Objective
Design an evidence-based, escalating pharmacotherapy plan for fluid resuscitation in critically ill burn patients.
1. Resuscitation Formulas and Selection Rationale
Standardized resuscitation formulas provide a critical starting point for estimating initial fluid volume requirements in severe burn injuries. However, these formulas are merely guides. Dynamic, hourly adjustment based on individual patient response and specific injury characteristics is essential to prevent the significant morbidity associated with both under- and over-resuscitation.
Common Resuscitation Formulas
- Parkland Formula: 4 mL/kg × % Total Body Surface Area (TBSA) of Lactated Ringer’s (LR) solution administered over 24 hours. Half of the total volume is given in the first 8 hours post-injury, with the remaining half delivered over the subsequent 16 hours.
- Modified Brooke Formula: 2 mL/kg × %TBSA of LR over 24 hours. Colloid administration is typically deferred until at least 24 hours post-injury.
- Evans Formula: A combination approach using 1.4 mL/kg × %TBSA of LR plus 0.7 mL/kg × %TBSA of colloid solution in the first 24 hours.
Key Pearls
- The Parkland formula is a starting point, not a prescription. Hourly titration based on urine output and other hemodynamic parameters is crucial to prevent “fluid creep”—the administration of excessive fluid volumes beyond what is necessary.
- Patients with deep thermal burns (full-thickness) or concomitant inhalation injury often exhibit a more profound inflammatory response and capillary leak, frequently requiring a 15–20% increase in fluid volume above the initial formula estimate.
Case Example: Applying the Parkland Formula
A 75 kg adult with 50% TBSA burns presents 4 hours post-injury.
- Calculate Total Volume: 4 mL × 75 kg × 50% TBSA = 15,000 mL (15 L) of LR.
- Calculate First 8-Hour Volume: 50% of 15 L = 7.5 L.
- Adjust for Time Delay: The patient presents 4 hours post-injury. The first 8-hour block is now only 4 hours long. The 7.5 L must be infused over the remaining 4 hours.
- Initial Infusion Rate: 7.5 L / 4 hr = 1.875 L/hr.
- Clinical Consideration: If deep burns or inhalation injury are present, consider increasing the initial rate by ~20% to approximately 2.25 L/hr, with immediate reassessment.
2. Crystalloids vs. Colloids: Pharmacotherapy Depth
The choice between crystalloid and colloid solutions is a central tenet of burn resuscitation. Lactated Ringer’s remains the first-line agent due to its balanced electrolyte profile and physiologic pH. Colloid rescue therapy, primarily with albumin, is reserved for specific indications such as refractory hypotension or massive crystalloid requirements, typically after the initial phase of capillary leak has begun to resolve.
Fluid Options
- Crystalloids (First-Line):
- Lactated Ringer’s (LR): The standard of care. It is a balanced, isotonic fluid whose lactate component is metabolized by the liver to bicarbonate, helping to buffer metabolic acidosis.
- Other Balanced Fluids (e.g., Plasma-Lyte): Use acetate and gluconate as buffers instead of lactate. May be considered in patients with severe liver failure.
- Colloid Rescue (Second-Line):
- Albumin 5%: Provides oncotic support to help retain fluid within the intravascular space. Typically initiated 8–12 hours post-burn if crystalloid requirements are massive (>200 mL/kg) or in the presence of severe hypoalbuminemia. A common dose is 0.5–1 g/kg infused over 2–4 hours.
- Hydroxyethyl Starch (HES 130/0.4): Its use is highly controversial and generally discouraged. It should only be considered if albumin is unavailable due to documented risks of coagulopathy and acute kidney injury (AKI).
Clinical Pearl: The Capillary Leak Phenomenon
In the first 8-12 hours after a major burn, systemic inflammation causes profound capillary leak, allowing fluids, electrolytes, and protein to escape the vasculature into the interstitial space. During this phase, crystalloids equilibrate rapidly, and administered colloids also leak out, offering little benefit. As capillary integrity begins to restore after this period, colloids like albumin become more effective at remaining intravascular and expanding plasma volume.
3. Dosing, Titration, and Monitoring
Effective burn resuscitation is a dynamic process. Fluid infusion rates must be adjusted hourly based on key physiological parameters to optimize end-organ perfusion while minimizing the risks of fluid overload, edema, and compartment syndromes.
Initiation & Titration Algorithm
-
Start Infusion: Begin LR infusion at the rate calculated by the Parkland formula (4 mL/kg/%TBSA).
-
Set Hourly Targets: Aim for the following goals:
- Urine Output (UO): 0.5 mL/kg/hr (in adults)
- Mean Arterial Pressure (MAP): ≥60 mm Hg
- Central Venous Oxygen Saturation (ScvO₂): ≥70%
- Hematocrit (Hct): 30–45%
-
Titrate Hourly: Based on UO, adjust the infusion rate up or down by approximately 10-20% each hour to maintain the target.
-
Escalate if Unresponsive:If resuscitation targets are not met after two consecutive hourly adjustments, administer a 250 mL LR fluid bolus, reassess, and strongly consider colloid rescue (albumin) or the initiation of vasopressor support.
Essential Monitoring
- Core Parameters: Hourly intake/output (I&O) and vital signs are mandatory.
- Laboratory Monitoring: Check hematocrit every 4–6 hours to assess hemoconcentration. Monitor electrolytes and acid-base status regularly.
Key Pearl: Interpreting Hematocrit
Hematocrit is a powerful indicator of resuscitation adequacy. A rising hematocrit, especially with hypotension, signals ongoing plasma loss and under-resuscitation. Conversely, a rapidly falling hematocrit in the setting of hypertension or worsening edema suggests over-resuscitation and hemodilution.
4. Special Populations and Fluid Adjustments
Fluid resuscitation must be carefully tailored in patients with pre-existing comorbid conditions that affect volume tolerance, such as renal disease or heart failure. Extremes of age also require specific considerations.
Renal Impairment
Patients with chronic kidney disease have a limited ability to excrete large fluid volumes. Consider reducing the initial crystalloid volume by 10–20% from the formula calculation and introducing colloid therapy earlier to minimize total volume. Maintain a low threshold for initiating early continuous renal replacement therapy (CRRT) if oliguria or signs of volume overload persist.
Heart Failure
Patients with pre-existing heart failure, particularly with reduced ejection fraction, are at high risk for iatrogenic pulmonary edema. Start resuscitation at approximately 75% of the calculated formula volume. Monitor preload indicators (e.g., CVP, POCUS) closely. It may be necessary to initiate low-dose norepinephrine early to support MAP and organ perfusion without relying solely on large fluid volumes.
Clinical Consideration: Pediatric & Geriatric Patients
Resuscitation in pediatric and geriatric populations requires significant modification. Pediatric patients have a larger body surface area to mass ratio, different TBSA charts (e.g., Lund-Browder), and require the addition of maintenance fluids containing dextrose to prevent hypoglycemia. Geriatric patients often have undiagnosed cardiac or renal dysfunction, making them highly susceptible to fluid overload. Both populations require meticulous monitoring and more conservative volume targets.
5. Infusion Logistics and Devices
The safe and effective delivery of high-volume fluid resuscitation depends on appropriate vascular access and reliable infusion devices. The choice of access impacts achievable flow rates and potential complications.
Vascular Access
- Peripheral IVs: The preferred initial access. Use large-bore catheters (14-16 gauge) placed in unburned skin. A single large-bore peripheral IV can deliver up to 3 L/hr. Rotate sites every 48-72 hours to minimize the risk of phlebitis and infection.
- Central Venous Catheters (CVCs): Reserved for patients requiring very high flow rates, those with poor peripheral access, or the need for invasive hemodynamic monitoring and frequent vasopressor titration. CVCs carry a higher risk of central line-associated bloodstream infections (CLABSI) and thrombosis.
Clinical Consideration: Infusion Pumps & Pressure Bags
While standard infusion pumps are precise, they may have maximum rate limitations that are insufficient for burn resuscitation. Pressure bags applied to fluid bags can significantly increase flow rates through peripheral IVs but require constant monitoring to prevent inadvertent bolusing or air embolism. Best practice involves using dedicated high-flow fluid warmers and pumps designed for trauma and burn care. All device settings, alarms, and backup protocols must be clearly defined in institutional guidelines, with hourly verification of volume infused versus the prescribed goal.
6. Pharmacoeconomic Analysis and Protocol Development
Institutional fluid resuscitation policies are driven by a balance of drug acquisition costs, the burden of monitoring, and the costs associated with managing complications. A standardized, evidence-based protocol is key to optimizing both clinical and economic outcomes.
Cost Comparison of Resuscitation Fluids
| Fluid | Approximate Acquisition Cost | Key Considerations |
|---|---|---|
| Lactated Ringer’s | ~$0.20 – $0.50 per Liter | First-line, low cost, widely available. High volumes required. |
| Albumin 5% | ~$20 – $30 per 250 mL | Significantly higher cost. Reserved for colloid rescue to reduce total volume and edema. |
| HES 130/0.4 | Variable | Use is discouraged. Potential for higher costs due to monitoring for and treating AKI/coagulopathy. |
Protocol Development and Quality Metrics
Effective institutional protocols should be monitored with key performance indicators, including:
- Adherence to formula-based initiation of fluids.
- Timeliness of hourly fluid rate adjustments based on urine output.
- Incidence of resuscitation-related complications, such as abdominal compartment syndrome, pulmonary edema, and acute kidney injury.
References
- Heimbach DM. A Historical Review of Fluid Resuscitation of the Burn Trauma Patient. Wounds. 2008;20(1):1–8.
- Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. Current Treatment of Severely Burned Patients. Ann Surg. 1996;223(1):14–25.
- Cartotto R, Johnson LS, Savetamal A, et al. American Burn Association Clinical Practice Guidelines on Burn Shock Resuscitation. J Burn Care Res. 2024;45(3):565–589.
- Hartmann B, et al. Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized controlled trial. Crit Care. 2013;17(6):R282.
- Vlachou E, Gosling P, Moiemen NS. Hydroxyethyl starch supplementation in burn resuscitation: a prospective randomized controlled trial. Burns. 2010;36(7):984–991.
- Mabrouk AR, Abdelsalam AM, Bakry SAD, et al. Effect of hydroxyethyl starch versus 5% albumin on intra-abdominal pressure in severe burn patients: a randomized clinical study. QJM. 2024;117(Suppl_1):hcae070.
- Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678–688.